U.S. Hospitality Stock News

Ligand Pharmaceuticals recently updated its long-term outlook, projecting 40% royalty revenue growth for 2026 and a 23% compound annual growth rate through 2030, supported by products including Filspari, Ohtuvayre and Capvaxive. The company also highlighted more than US$1.00 billion in deployable capital for new royalty deals targeting unmet medical needs, underlining its capacity to expand the portfolio further. We’ll now examine how this upgraded royalty growth outlook, underpinned by...

In recent days, VNET Group announced plans to build 10 GW of green computing capacity and launched its Hyperscale 2.0 AI data center initiative across multiple regions in China, while broader optimism around US-listed Chinese stocks was reinforced by bullish commentary on AI-driven growth and policy support. This combination highlights how VNET is positioning its infrastructure toward AI-focused, energy-efficient data centers at the same time investors are reassessing AI-related...

Worthington Steel (WS) is back in focus after its latest Form 10-Q highlighted financial and operational performance tied to automotive demand, the Sitem Group acquisition in Europe, and increased use of AI and technology. See our latest analysis for Worthington Steel. The recent Form 10-Q, the Sitem Group acquisition in Europe and the push into AI supported operations are all landing against a share price of $36.93, with a 90 day share price return of 20.41% and a 1 year total shareholder...

Empire State Realty Trust recently signed a lease with Tourneau, LLC for a 3,767 sq ft Rolex retail store at 86 North Sixth Street in Williamsburg, Brooklyn, and previously announced that its fourth-quarter 2025 results will be released on February 17, 2026, followed by a conference call on February 18, 2026. The addition of a high-profile luxury tenant to ESRT's North Sixth Street Collection underscores the appeal of its Williamsburg retail cluster to premium brands and may reinforce the...

Sabra Health Care REIT (SBRA) has reshaped its senior leadership, appointing long time executive Darrin Smith as Chief Investment Officer, Secretary and Executive Vice President following Talya Nevo Hacohen’s retirement at the end of 2025. See our latest analysis for Sabra Health Care REIT. The leadership change comes as Sabra’s share price trades at US$19.28, with a 90 day share price return of 9.36% and a 1 year total shareholder return of 24.22%. This suggests momentum has been building...

Tanger Inc. recently upsized and priced a US$220 million offering of 2.375% exchangeable senior notes due 2031, alongside new unsecured term loans totaling US$550 million, to refinance debt, support share repurchases, and bolster liquidity. By pairing exchangeable notes with capped call transactions and extending its debt maturities into the next decade, Tanger is explicitly prioritizing balance sheet flexibility while seeking to limit future share dilution for existing investors. We’ll now...

AdvanSix Inc. ( NYSE:ASIX ) shareholders should be happy to see the share price up 13% in the last month. Meanwhile...

Key Insights Humacyte's significant retail investors ownership suggests that the key decisions are influenced by...

Why Navios Maritime Partners is in focus after Q3 2025 Navios Maritime Partners (NMM) hit a 52 week high after reporting Q3 2025 results that topped analyst expectations for earnings and revenue, alongside senior leadership promotions tied to a broader corporate restructuring. See our latest analysis for Navios Maritime Partners. The stock’s 8.7% 7 day share price return and 26.3% 90 day share price return suggest momentum has been building ahead of and around the Q3 2025 earnings beat and...

As the U.S. stock market navigates a mixed landscape with major indices showing varied performances and precious metals reaching record highs, investors are closely watching economic indicators and political developments that could influence market dynamics. In this environment, identifying undervalued stocks can be particularly appealing, as these opportunities may offer potential value when broader market conditions create uncertainty.

Major stock indexes in the United States are experiencing mixed performance, with gold and silver reaching record highs amid a Justice Department probe into Federal Reserve Chair Jerome Powell. In such a fluctuating market landscape, penny stocks can present unique opportunities for investors seeking growth at lower price points. Though often associated with smaller or newer companies, these stocks can offer significant potential when backed by strong financials and sound fundamentals.

In the current U.S. market landscape, major stock indexes are showing mixed performances amid heightened scrutiny of Federal Reserve actions and record highs in gold and silver prices. As investors navigate this complex environment, dividend stocks like Civista Bancshares offer a potential avenue for stability and income, making them an attractive consideration for those seeking to bolster their portfolios against economic uncertainties.

Harmonic (HLIT) has been drawing attention after recent share price moves, with the stock last closing at $9.63. For investors, the key question is how this level lines up with fundamentals. See our latest analysis for Harmonic. Recent moves sit against a weaker backdrop, with a 30 day share price return of a 6.32% decline and a 1 year total shareholder return of a 22.59% loss, suggesting momentum has been fading despite the current US$9.63 level. If Harmonic has you reassessing opportunities...

Comstock Resources, Inc.'s ( NYSE:CRK ) price-to-sales (or "P/S") ratio of 3.5x may not look like an appealing...

Pacira BioSciences recently reported preliminary unaudited 2025 revenue of US$726.4 million, modestly above the prior year’s US$701.0 million, while also completing a US$150.05 million buyback totaling 5,932,106 shares since May 2025. At the same time, the company lowered its 2025 revenue forecast and faced fresh pressure from activist DOMA Perpetual Capital Management, which is pushing for board changes and a potential sale process. Next, we’ll examine how the downward 2025 revenue forecast...

Penumbra recently presented at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, while ongoing SEC filings show continued small share sales by Director Harpreet Grewal over the past year with no insider purchases reported. Analyst commentary highlighting Penumbra’s emerging middle meningeal artery embolization franchise, alongside recent strong quarterly results and raised 2025 revenue guidance, is sharpening investor focus on the company’s embolization growth...

In recent days, industrial names including Albany International Corp. rallied after investors reacted to a proposed US$1.50 trillion US defense budget for 2027 and improving energy cost stability, which together lifted sentiment toward defense-linked and heavy industry companies. The move highlights how policy-driven defense spending expectations can spill over into adjacent manufacturers such as Albany, even without company-specific announcements. Against this backdrop of renewed interest...

Kaiser Aluminum has appointed Hugh (Jack) J. Barger, III as Executive Vice President – Sales and Marketing effective January 1, 2026, while former commercial leader Blain A. Tiffany moved into an Advisor to the CEO role under a planned succession that is now underway. This carefully phased handover of commercial leadership highlights Kaiser Aluminum’s emphasis on continuity in customer relationships and sales execution during 2026. Next, we’ll consider how this planned shift in sales and...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

As the U.S. stock market reaches new highs, with major indices like the Dow and S&P 500 closing at record levels, small-cap stocks are capturing attention for their potential to outperform in this dynamic environment. With economic indicators showing a mix of strengths and challenges, identifying promising small-cap opportunities involves looking at factors such as earnings resilience and strategic insider actions that align with broader market trends.

As the United States markets kick off 2026 with record highs in major indices like the Dow and S&P 500, investors are keeping a keen eye on tech stocks, particularly those poised for high growth. In this favorable economic climate, characterized by a declining unemployment rate and robust index performance, identifying tech companies with strong innovation potential and solid financial health can be crucial for navigating the evolving landscape of high-growth opportunities.

As the Dow and S&P 500 close at record highs, reflecting a strong start to 2026, investors are keenly observing the broader market dynamics shaped by recent economic indicators and policy developments. In this environment of heightened market performance, identifying undervalued stocks becomes crucial for those looking to capitalize on potential growth opportunities amidst these record-setting indices.

The U.S. stock market has started 2026 with a bang, as major indexes like the Dow Jones Industrial Average and S&P 500 have hit record highs following a week of strong gains. This robust performance sets an intriguing backdrop for exploring investment opportunities in penny stocks, which often represent smaller or newer companies that can offer significant growth potential. Despite their somewhat outdated name, penny stocks remain relevant for investors seeking affordability combined with the...

As the U.S. stock market continues to reach new heights with the Dow and S&P 500 closing at record levels, small-cap stocks are gaining attention due to their potential for outperformance in a climate of accommodative monetary policy and improving earnings prospects. In this environment, identifying undiscovered gems within the small-cap sector requires a keen eye for companies that combine strong fundamentals with growth potential, offering unique opportunities amid broader market optimism.